FMR CORP 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 09:55 am Sale |
2024-11-08 | 13G | Century Therapeutics, Inc. IPSC |
FMR CORP | 2,521,511 2.976% |
-1,091,040 (-30.20%) |
Filing |
| 2024-02-09 08:50 am Sale |
2024-02-08 | 13G | Century Therapeutics, Inc. IPSC |
FMR CORP | 3,612,551 6.037% |
-210,714 (-5.51%) |
Filing |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Century Therapeutics, Inc. IPSC |
FMR CORP | 3,823,265 6.397% |
-3,273,146 (-46.12%) |
Filing |
| 2023-02-09 09:59 am Sale |
2023-02-09 | 13G | Century Therapeutics, Inc. IPSC |
FMR CORP | 7,096,411 12.033% |
-1,099,792 (-13.42%) |
Filing |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Century Therapeutics, Inc. IPSC |
FMR CORP | 8,196,203 14.999% |
943,642 (+13.01%) |
Filing |
| 2021-08-10 10:33 am Purchase |
2021-08-09 | 13G | Century Therapeutics, Inc. IPSC |
FMR CORP | 7,252,561 12.857% |
7,252,561 (New Position) |
Filing |